Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load
about
IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platformGenotypes and transmitted drug resistance among treatment-naive HIV-1-infected patients in a northwestern province, China: trends from 2003 to 2013The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infectionLocal phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions.Prevalence of Drug Resistance and Associated Mutations in a Population of HIV-1(+) Puerto Ricans: 2006-2010.Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients.Low prevalence of transmitted K65R and other tenofovir resistance mutations across different HIV-1 subtypes: implications for pre-exposure prophylaxis.Social network-based recruitment successfully reveals HIV-1 transmission networks among high-risk individuals in El Salvador.Characteristics and genotype profiles of antiretroviral-naïve patients entering a Southern US HIV outpatient clinic 2009-2012.Prevalence and trends in transmitted and acquired antiretroviral drug resistance, Washington, DC, 1999-2014.Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide.Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011.Baseline-transmitted V106V/I/M non-nucleoside reverse transcriptase inhibitor resistance in HIV-1 subtype B infection.International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK
P2860
Q28543211-763F4BEC-D954-4B03-87F9-0013C0E9649EQ28543775-D509EBA8-68BB-4591-BEF9-B394203A74B6Q33806894-1B2724BD-EB42-4C93-863F-B0BDC516E9C6Q34484449-EB4AB675-1CF1-4F0B-B6C4-3FF539E9C651Q35028707-493C21E3-CB83-4F18-91BE-C56A60B0C4E1Q35944787-E99778BC-A53B-4313-AB75-6E892DBCE5FCQ36279238-D78FD299-1A39-4E2E-B64F-A6C5629F13D0Q36386787-9C9FFC85-FA87-42E9-A5E0-FABC81774DF9Q36812984-AC444ACD-56D8-4982-8236-656079B9F454Q38504434-81FE1991-B989-41F1-AD30-53C81A1BBC09Q40047145-8769BCFA-F972-4711-B018-D03ABA26D0E3Q40223002-7E973A38-D1DB-460D-9EBC-3C8DBBF264C9Q40934127-A4D74838-1655-4F24-86C7-BC2B79A0DD74Q41812289-EF87DF08-92BF-4728-9698-0573C6210A30Q56762706-7CD71881-B76F-47F4-83FD-4FEA561F6410
P2860
Transmitted drug resistance in the CFAR network of integrated clinical systems cohort: prevalence and effects on pre-therapy CD4 and viral load
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@ast
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@en
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@nl
type
label
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@ast
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@en
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@nl
prefLabel
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@ast
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@en
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@nl
P2093
P2860
P50
P3181
P1433
P1476
Transmitted drug resistance in ...... pre-therapy CD4 and viral load
@en
P2093
James S Kahn
Jeannette L Aldous
Mari Kitahata
Michael S Saag
Richard H Haubrich
Stephen L Boswell
W Christopher Mathews
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0021189
P407
P577
2011-06-20T00:00:00Z